Literature DB >> 15737566

European multi-centre case-control study on risk factors for rare cancers of unknown aetiology.

Elsebeth Lynge1, Noemia Afonso, Linda Kaerlev, Jørn Olsen, Svend Sabroe, Wolfgang Ahrens, Mikael Eriksson, Pascal Guénel, Franco Merletti, Aivars Stengrevics, Maria Suarez-Varela, Altamiro Costa-Pererra, Mogens Vyberg.   

Abstract

To search for occupational risk factors, we conducted a case-control study in nine European countries of cancers of the small intestine, male gall bladder, thymus, bone, male breast, melanoma of the eye, and mycosis fungoides. Recruitment was population based in Denmark, Latvia, France, Germany, Italy, and Sweden, from hospital areas in Spain and Portugal, and from one United Kingdom (UK) hospital. We recruited 1457 cases (84% interviewed). Numbers identified corresponded to those in the EUROCIM database for Denmark, but were below those observed for France, Italy and Sweden in the database. We recruited 3374 population (61% interviewed) and 1284 colon cancer controls (86% interviewed). It was possible to undertake this complicated study across Europe, but we encountered three main problems. It was difficult to ensure complete case ascertainment, for population controls, we found a clear divide in the response rate from 75% in the South to only 55% in the North, and a somewhat selective recruitment was noted for the colon cancer controls. The study showed there is a clear dose-response relationship between alcohol intake and the risk of male breast cancer, and an excess risk of mycosis fungoides among glass formers, pottery and ceramic workers. Further data are expected.

Entities:  

Mesh:

Year:  2005        PMID: 15737566     DOI: 10.1016/j.ejca.2004.12.016

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  7 in total

1.  Breast cancer in priests: follow-up of an observation made 167 years ago.

Authors:  Lin Fritschi; Pascal Guenel; Wolfgang Ahrens
Journal:  Eur J Epidemiol       Date:  2010-01-21       Impact factor: 8.082

2.  Occupation and occupational exposure to endocrine disrupting chemicals in male breast cancer: a case-control study in Europe.

Authors:  Sara Villeneuve; Diane Cyr; Elsebeth Lynge; Laurent Orsi; Svend Sabroe; Franco Merletti; Giuseppe Gorini; Maria Morales-Suarez-Varela; Wolfgang Ahrens; Cornelia Baumgardt-Elms; Linda Kaerlev; Mikael Eriksson; Lennart Hardell; Joëlle Févotte; Pascal Guénel
Journal:  Occup Environ Med       Date:  2010-08-25       Impact factor: 4.402

3.  A case-control study: occupational cooking and the risk of uveal melanoma.

Authors:  Andrea Schmidt-Pokrzywniak; Karl-Heinz Jöckel; Anja Marr; Norbert Bornfeld; Andreas Stang
Journal:  BMC Ophthalmol       Date:  2010-10-22       Impact factor: 2.209

4.  Staphylococcal enterotoxin A (SEA) stimulates STAT3 activation and IL-17 expression in cutaneous T-cell lymphoma.

Authors:  Andreas Willerslev-Olsen; Thorbjørn Krejsgaard; Lise M Lindahl; Ivan V Litvinov; Simon Fredholm; David L Petersen; Claudia Nastasi; Robert Gniadecki; Nigel P Mongan; Denis Sasseville; Mariusz A Wasik; Charlotte M Bonefeld; Carsten Geisler; Anders Woetmann; Lars Iversen; Mogens Kilian; Sergei B Koralov; Niels Odum
Journal:  Blood       Date:  2016-01-05       Impact factor: 22.113

5.  An international comparison of male and female breast cancer incidence rates.

Authors:  Diana Ly; David Forman; Jacques Ferlay; Louise A Brinton; Michael B Cook
Journal:  Int J Cancer       Date:  2012-10-12       Impact factor: 7.396

6.  Risk factors for breast cancer, including occupational exposures.

Authors:  Elisabete Weiderpass; Margrethe Meo; Harri Vainio
Journal:  Saf Health Work       Date:  2011-03-31

Review 7.  Bacterial toxins fuel disease progression in cutaneous T-cell lymphoma.

Authors:  Andreas Willerslev-Olsen; Thorbjørn Krejsgaard; Lise M Lindahl; Charlotte Menne Bonefeld; Mariusz A Wasik; Sergei B Koralov; Carsten Geisler; Mogens Kilian; Lars Iversen; Anders Woetmann; Niels Odum
Journal:  Toxins (Basel)       Date:  2013-08-14       Impact factor: 4.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.